Showing results (461-470 of 606) with videos related to
Sort By:
Pageof 61
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.Cancer|August 19, 2020
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemiaSeth E Karol, Todd M Cooper, Paul E Mead, et al.Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.Leukemia|August 26, 2022
Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemiaBrennan P Bergeron, Jonathan D Diedrich, Yang Zhang, et al.Plos Computational Biology|February 5, 2016
MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene ExpressionSteven W Paugh, David R Coss, Ju Bao, et al.Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary TrialsElizabeth A Raetz, Paola Rebora, Valentino Conter, et al.The Lancet. Haematology|July 8, 2026
Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion studyKatelyn P Daniels, Stanley B Pounds, Huiyun Wu, et al.Pageof 61